Published in Lab Business Week, May 22nd, 2005
This document, required by the SEC, discloses the company's financial statements for periods ending December 31, 2004.
"This is an important step for Advanced Cell Technology - our timely filing on Form 8K of financial statements required following our recent merger transaction," said James Stewart, chief financial officer of Advanced Cell Technology.
"ACT looks forward to providing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.